Prestige Consumer Healthcare Inc (NYSE:PBH) has earned a consensus rating of “Hold” from the seven research firms that are covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and three have given a buy rating to the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $82.75.
Several equities research analysts have recently commented on the stock. BMO Capital Markets raised their target price on shares of Prestige Consumer Healthcare from $92.00 to $106.00 and gave the stock an “outperform” rating in a research report on Thursday, January 30th. ValuEngine cut shares of Prestige Consumer Healthcare from a “sell” rating to a “strong sell” rating in a research report on Monday, December 16th. DA Davidson reaffirmed a “neutral” rating on shares of Prestige Consumer Healthcare in a research report on Friday, February 7th. Finally, Zacks Investment Research raised shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating and set a $44.00 target price for the company in a research report on Tuesday, December 31st.
Hedge funds and other institutional investors have recently modified their holdings of the stock. Citizens Financial Group Inc RI purchased a new position in Prestige Consumer Healthcare during the 4th quarter valued at about $25,000. Oppenheimer Asset Management Inc. lifted its position in Prestige Consumer Healthcare by 113.6% during the 3rd quarter. Oppenheimer Asset Management Inc. now owns 771 shares of the company’s stock valued at $27,000 after acquiring an additional 410 shares during the period. Bridger Capital Management LLC purchased a new position in Prestige Consumer Healthcare during the 3rd quarter valued at about $52,000. Tower Research Capital LLC TRC lifted its position in Prestige Consumer Healthcare by 100.6% during the 3rd quarter. Tower Research Capital LLC TRC now owns 1,657 shares of the company’s stock valued at $57,000 after acquiring an additional 831 shares during the period. Finally, Chevy Chase Trust Holdings Inc. purchased a new position in Prestige Consumer Healthcare during the 4th quarter valued at about $68,000.
Shares of NYSE:PBH traded down $0.11 on Friday, hitting $42.40. The company had a trading volume of 268,156 shares, compared to its average volume of 442,513. The firm’s 50-day simple moving average is $41.60 and its two-hundred day simple moving average is $37.29. Prestige Consumer Healthcare has a 1 year low of $26.49 and a 1 year high of $46.12. The company has a quick ratio of 1.20, a current ratio of 2.02 and a debt-to-equity ratio of 1.50. The firm has a market capitalization of $2.14 billion, a price-to-earnings ratio of -67.30, a P/E/G ratio of 2.28 and a beta of 0.94.
Prestige Consumer Healthcare (NYSE:PBH) last posted its earnings results on Thursday, February 6th. The company reported $0.81 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.75 by $0.06. Prestige Consumer Healthcare had a negative net margin of 3.57% and a positive return on equity of 13.17%. The firm had revenue of $241.60 million during the quarter, compared to analysts’ expectations of $240.34 million. During the same period last year, the company posted $0.73 EPS. The company’s quarterly revenue was up .1% compared to the same quarter last year. Equities research analysts anticipate that Prestige Consumer Healthcare will post 2.87 EPS for the current year.
About Prestige Consumer Healthcare
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.
Read More: Why does a company issue an IPO?
Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.